{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:58:00Z","timestamp":1783508280266,"version":"3.55.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\nBackground<\/jats:title>\nRheumatoid arthritis (RA) is an autoimmune systemic chronic inflammatory disorder, which is characterized by joint stiffness, damage, and destruction of bone. In RA patients, the risk of cardiovascular disease is increased by 2\u20133 folds as compared to the general population. The major burden of RA is the development of cardiovascular diseases, including congestive heart failure, stroke, and myocardial infarction.<\/jats:p>\n<\/jats:sec>\n\nObjectives<\/jats:title>\nAssessment of the association of atherogenic indices with C-reactive protein to evaluate CVD risk was one of the purposes of this study. In addition, the association of atherogenic indices with elevated levels of cardiovascular risk factors (LDL-C and TG) was another aim of this study.<\/jats:p>\n<\/jats:sec>\n\nMethods<\/jats:title>\nThe preferred study design for this study was a hospital based comparative cross-sectional study method. Data were cleaned, coded, and entered into Epi Data version 4.6 software, and exported to SPSS version 20 for further analysis of atherogenic indices, C-reactive protein, and risk factors. The comparison of atherogenic indices and other variables among the case and control groups was estimated by the independent t-test statistical analysis method. All variables with a p-value less than 0.2 during binary linear regression analysis were selected for multinomial logistic regression analysis. The association of atherogenic indices with C-reactive protein and risk factors was computed using multiple logistic regressions. The data were presented using tables and figures for clarification of the study.<\/jats:p>\n<\/jats:sec>\n\nResults<\/jats:title>\nThe levels of atherogenic indices were computed for both RA patients and the control group. The values of atherogenic indices were significantly associated with cardiovascular risk factor (CRP \u2265 2mg\/L). Atherogenic index of plasma (AIP) and TC\/HDL-C ratio had a statistically significant association with an elevated levels of triglycerides (P<0.01). The TC\/HDL-Cratio value of the patient had 2.38 folds more likely to have an elevated low density lipoprotein level. In addition, AIP of RA patients had 57.51 and 23.65 folds more to have elevated low density lipoprotein and triglycerides respectively.<\/jats:p>\n<\/jats:sec>\n\nConclusions<\/jats:title>\nThe result of this study showed that TC\/HDL-C, LDL\/HDL-C ratio values, and atherogenic index of plasma had a statistically significant association with elevated level of low density lipoprotein and triglycerides. In addition to this, they have a statistically significant association with the level of C-reactive protein. There was a highly significant statistical association between atherogenic indices, elevated low density lipoprotein, and triglycerides values. Therefore, the result of this finding confirmed that atherogenic indices have a potential role in the prediction and management of CVD risk in RA patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0269431","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T17:35:53Z","timestamp":1654277753000},"page":"e0269431","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2311-6180","authenticated-orcid":true,"given":"Gashaw","family":"Dessie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"pone.0269431.ref001","doi-asserted-by":"crossref","first-page":"452","DOI":"10.18535\/jmscr\/v6i8.72","article-title":"A Comparative Study of Lipid Profile and Atherogenic Index of Plasma among Women with Rheumatoid Arthritis and without Rheumatoid Arthritis","volume":"6","author":"S Thota","year":"2018","journal-title":"JMSCR"},{"issue":"3","key":"pone.0269431.ref002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5937\/afmnai1903177A","article-title":"The impact of disease activity in patients with rheumatoid arthritis on metabolic syndrome and cardiovascular risk assessment","volume":"36","author":"I Aleksi\u0107","year":"2019","journal-title":"Acta facultatis medicae Naissensis"},{"issue":"5","key":"pone.0269431.ref003","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s12265-020-09964-9","article-title":"Cardiovascular risk assessment and therapeutic implications in rheumatoid arthritis","volume":"13","author":"J Halacoglu","year":"2020","journal-title":"Journal of cardiovascular translational research"},{"key":"pone.0269431.ref004","article-title":"The JAK\u2013STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","author":"C Baldini","year":"2021","journal-title":"European Heart Journal"},{"key":"pone.0269431.ref005","author":"S Dabeer","journal-title":"Correlation between CRP and Atherogenic Index and Assessment of Cardiovascular Disease Risk in Patients with Rheumatic Arthritis"},{"key":"pone.0269431.ref006","first-page":"1","article-title":"Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry","author":"HK Min","year":"2021","journal-title":"Clinical Rheumatology"},{"issue":"5","key":"pone.0269431.ref007","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10067-018-4027-0","article-title":"Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis","volume":"37","author":"E Cure","year":"2018","journal-title":"Clinical rheumatology"},{"key":"pone.0269431.ref008","article-title":"Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals","volume":"2012","author":"CD Popa","year":"2012","journal-title":"Mediators of inflammation"},{"issue":"1","key":"pone.0269431.ref009","first-page":"53","article-title":"Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study","volume":"11","author":"K Hajian-Tilaki","year":"2020","journal-title":"Caspian journal of internal medicine"},{"key":"pone.0269431.ref010","doi-asserted-by":"crossref","DOI":"10.1186\/s42358-019-0096-2","article-title":"Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?","volume":"59","author":"D Tecer","year":"2019","journal-title":"Advances in Rheumatology"},{"issue":"1","key":"pone.0269431.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12947-018-0136-9","article-title":"Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis","volume":"16","author":"B Targo\u0144ska-St\u0119pniak","year":"2018","journal-title":"Cardiovascular ultrasound"},{"issue":"8","key":"pone.0269431.ref012","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00296-020-04616-2","article-title":"The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk","volume":"40","author":"AI Venetsanopoulou","year":"2020","journal-title":"Rheumatology International"},{"issue":"10","key":"pone.0269431.ref013","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/life11101042","article-title":"Ischemic Heart Disease and Rheumatoid Arthritis\u2014Two Conditions, the Same Background","volume":"11","author":"E Rezu\u0219","year":"2021","journal-title":"Life"},{"issue":"3","key":"pone.0269431.ref014","article-title":"Inflammation beyond the joints: rheumatoid arthritis and cardiovascular disease","volume":"2","author":"A Urman","year":"2018","journal-title":"SciFed journal of cardiology"},{"key":"pone.0269431.ref015","first-page":"1","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging","author":"AD Jamthikar","year":"2020","journal-title":"Rheumatology international"},{"issue":"40","key":"pone.0269431.ref016","first-page":"41","article-title":"Comparison and detection the level of C Reactive Protein in different age groups on patients of Rheumatoid Arthritis at tertiary care centre of Kanpur (UP)","volume":"20","author":"P Gupta","journal-title":"Age (years)"},{"key":"pone.0269431.ref017","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2020.44","article-title":"Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment","volume":"16","author":"AM Kerola","year":"2021","journal-title":"European Cardiology Review"},{"issue":"9","key":"pone.0269431.ref018","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41440-020-0483-4","article-title":"Cardiovascular disease and subclinical atherosclerosis in rheumatoid arthritis","volume":"43","author":"S Hannawi","year":"2020","journal-title":"Hypertension Research"},{"issue":"9","key":"pone.0269431.ref019","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41440-020-0441-1","article-title":"Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients","volume":"43","author":"A Dalbeni","year":"2020","journal-title":"Hypertension Research"},{"issue":"1","key":"pone.0269431.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41927-018-0014-y","article-title":"Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment","volume":"2","author":"A Jagpal","year":"2018","journal-title":"BMC rheumatology"},{"key":"pone.0269431.ref021","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3265847","article-title":"Gender differences in cardiovascular risk profile in rheumatoid arthritis patients with low disease activity","volume":"2019","author":"B Targo\u0144ska-St\u0119pniak","year":"2019","journal-title":"BioMed research international"},{"issue":"9","key":"pone.0269431.ref022","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/rheumatology\/kez081","article-title":"Association between socioeconomic status and comorbidities among patients with rheumatoid arthritis: results of a nationwide cross-sectional survey","volume":"58","author":"A Shin","year":"2019","journal-title":"Rheumatology"},{"issue":"1\u20132","key":"pone.0269431.ref023","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/08820139.2019.1631844","article-title":"Plasma leptin does not reflect the effect of high body mass index on disease activity in rheumatoid arthritis","volume":"49","author":"M Taghadosi","year":"2020","journal-title":"Immunological investigations"},{"issue":"3","key":"pone.0269431.ref024","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ihj.2013.04.035","article-title":"Relationship of high-sensitive C-reactive protein with cardiovascular risk factors, clinical presentation and angiographic profile in patients with acute coronary syndrome: An Indian perspective","volume":"65","author":"S Gupta","year":"2013","journal-title":"Indian heart journal"},{"issue":"4","key":"pone.0269431.ref025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.injr.2013.06.006","article-title":"Evaluation of dyslipidaemia in patients with rheumatoid arthritis in South Indian population","volume":"8","author":"KS Vinapamula","year":"2013","journal-title":"Indian Journal of Rheumatology"},{"issue":"3","key":"pone.0269431.ref026","doi-asserted-by":"crossref","first-page":"87","DOI":"10.22631\/rr.2019.69997.1071","article-title":"Correlation between lipid profile and lipoprotein (a) with inflammatory activity of rheumatoid arthritis","volume":"4","author":"Z Rezaieyazdi","year":"2019","journal-title":"Rheumatology Research"},{"issue":"24","key":"pone.0269431.ref027","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"SM Grundy","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"pone.0269431.ref028","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamacardio.2019.0771","article-title":"Four Cases of Cholesterol Management Informed by the 2018 American Heart Association\/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol","volume":"4","author":"S Chuzi","year":"2019","journal-title":"JAMA cardiology"},{"key":"pone.0269431.ref029","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2453265","article-title":"Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment","volume":"2018","author":"F Cacciapaglia","year":"2018","journal-title":"Mediators of inflammation"},{"issue":"11","key":"pone.0269431.ref030","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s10067-015-3049-0","article-title":"Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment","volume":"34","author":"M Akiyama","year":"2015","journal-title":"Clinical rheumatology"},{"issue":"11","key":"pone.0269431.ref031","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/annrheumdis-2017-211708","article-title":"Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis","volume":"76","author":"J Robertson","year":"2017","journal-title":"Annals of the rheumatic diseases"},{"issue":"12","key":"pone.0269431.ref032","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.clinbiochem.2013.03.023","article-title":"Atherogenic lipid profile and high sensitive C-reactive protein in patients with rheumatoid arthritis","volume":"46","author":"HV Singh","year":"2013","journal-title":"Clinical biochemistry"},{"key":"pone.0269431.ref033","article-title":"Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation","author":"B Weber","year":"2021","journal-title":"Arthritis & Rheumatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T17:36:22Z","timestamp":1654277782000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269431"}},"subtitle":[],"editor":[{"given":"Gualtiero I.","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0269431","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]}}}